Clinical Trial

Efficacy and Safety Study of Aprepitant Injection for Prevention of Post-operative Nausea and Vomiting

Not Yet Recruiting Phase 3
View on ClinicalTrials.gov →
Record status
This record was last updated August 9, 2024 (before its estimated March 28, 2026 completion). Its status may not reflect the trial's current state.
Summary
A randomized, double-blind, placebo-controlled, multi-center phase III study to compare the efficacy and safety of aprepitant injection and placebo in the prevention of post-operative nausea and vomiting (PONV).,
Trial Details
NCT Number NCT06543966
Lead Sponsor CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.
Conditions Post-operative Nausea and Vomiting (PONV)
Enrollment 486 participants
Start Date 2024-10-28
Primary Completion 2026-03-28 (estimated)
Study Completion 2026-03-28 (estimated)
Updated on ClinicalTrials.gov 2024-08-09